ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 603071 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 603071; 2) Community: the network communities that were significantly associated with the response to NSC 603071; 3) Molecule: the relationships between components within communities and NSC 603071; 4) MDR: the compounds that were significantly associated with the NSC 603071.

NSC Compound Enrichment Correlation
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0385613993886001 0.066262249
NSC 179187 Salasdine 0.0385613993886001 0.13991869
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0385613993886001 0.61987987
NSC 279836 Mitoxantrone 0.0385613993886001 0.70005587
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.0385613993886001 0.42508591
NSC 604586 2-Butenamide, N-(4-chlorophenyl)-4,4,4-trichloro- 0.0385613993886001 0.17875034
NSC 620256 Platinate(2-), tetrachloro-, (SP-4-1), 9-hydroxy-2,5,11- trimethyl-6H-pyrido[4,3-b]carbazolium (1:2) 0.0385613993886001 0.47413575
NSC 626760 Null 0.0385613993886001 0.050566938
NSC 629 Bioxiran 0.0385613993886001 0.5074495
NSC 636679 Null 0.0385613993886001 0.017730686
Total:61  Current:48    [First] [Prev] [Next] [Last]